A microtitre cytotoxicity assay useful for the discovery of fermentation-derived antitumor agents

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Screening fermentation broths for antitumor agents is crucial for drug discovery.
• Traditional antimicrobial assays have limitations in predicting in vivo antitumor activity.
• Mammalian cell-based assays offer a potential alternative for more accurate screening.

Purpose of the Study:

• To develop and validate a microtiter cytotoxicity assay using mammalian cell lines for detecting fermentation-derived antitumor agents.
• To compare the efficacy of this new assay with standard antimicrobial assays in predicting in vivo activity.

Main Methods:

• Developed a microtiter cytotoxicity assay utilizing two murine (AKR, B16) and four human (HTB-31, KB, MOSER, RCA) cell lines.
• Evaluated 2000 fermentation broth supernatants for cytotoxic activity.
• Compared results with standard antimicrobial assays and subsequent in vivo testing (P388).

Main Results:

• Mammalian cell lines exhibited diverse spectra of activity against fermentation broths.
• Approximately 30% overlap was observed between cytotoxicity and antimicrobial assay results.
• The cytotoxicity assay showed a 40% predictive rate for in vivo activity, twice that of antimicrobial assays.

Conclusions:

• The developed mammalian cell-based cytotoxicity assay is a more effective tool for screening fermentation broths for antitumor agents.
• This assay improves the prediction of in vivo antitumor activity compared to traditional antimicrobial screening.
• The findings support the utility of cell-based assays in the early stages of anticancer drug discovery.